Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Mnemosyne Pharmaceuticals
Mnemosyne Pharmaceuticals
Reports Graph
First-in-class subunit-selective NMDA receptor modulators to treat neuropsychiatric diseases, specifically schizophrenia and Alzheimer\'s
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next